|

ESK981 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CEP-11981

Pipeline

Phase 2: 1

Top Sponsors

  • University of Michigan Rogel Cancer Center1

Indications

  • Neuroendocrine Prostate Carcinoma1
  • Gastrointestinal Neuroendocrine Carcinoma1
  • Pancreatic Neuroendocrine Carcinoma1
  • Gastrointestinal Neuroendocrine Tumor1
  • Adenosquamous Carcinoma1

Ann Arbor, Michigan1 trial

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

Rogel Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.